Apligraf: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m wikify skin |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | <!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | ||
Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb | '''Apligraf''' is a synthetic [[skin]] created from harvested foreskins.<ref>{{REFweb | ||
| quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | |quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | ||
| url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | |url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | ||
| title=Apligraf: How Is It Made? | |title=Apligraf: How Is It Made? | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=Organogenesis | |publisher=Organogenesis | ||
| date= | |date= | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> It is [[FDA]] approved,<ref>{{REFweb | }}</ref> It is [[FDA]] approved,<ref>{{REFweb | ||
| quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | |quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | ||
| url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | |url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html | ||
| title=Apligraf | |title=Apligraf | ||
| last= | |last= | ||
| first= | |first= | ||
| publisher=Organogenesis | |publisher=Organogenesis | ||
| date= | |date= | ||
| accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
}}</ref> and it is made and sold by [[Organogenesis]], | }}</ref> and it is made and sold by [[Organogenesis]], a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. | ||
== Apligraph Oral == | == Apligraph Oral == | ||
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | ||
| last= | |last= | ||
| first | |first= | ||
|url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | |||
| url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | |title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | ||
| title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | |date=2011-11-17 | ||
| date= | |publisher=FDA | ||
| publisher=FDA | |quote= | ||
| quote= | |accessdate=2011-12-20 | ||
| accessdate=2011-12-20 | |||
}}</ref> | }}</ref> | ||
<!-- 404: Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf --> | |||
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf | |||
{{REF}} | {{REF}} | ||
[[Category:Foreskin | [[Category:Foreskin product]] | ||
[[Category:Financial | [[Category:Financial gain]] | ||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
[[de:{{FULLPAGENAME}}]] | |||
Latest revision as of 14:56, 27 December 2021
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑
Apligraf: How Is It Made?
, Organogenesis. Retrieved 6 March 2011.
Quote:Human keratinocytes and fibroblasts are derived from neonatal foreskins
- ↑
Apligraf
, Organogenesis. Retrieved 6 March 2011.
Quote:Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
- ↑
(17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.
